Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 33,00 € Taxes included to order
    Pages Iconography Videos Other
    5 2 0 0


Joint Bone Spine
Volume 80, n° 6
pages 645-649 (décembre 2013)
Doi : 10.1016/j.jbspin.2013.03.004
accepted : 5 Mars 2013
Myositis in a patient with familial Mediterranean fever and spondyloarthritis successfully treated with anakinra
 

Charline Estublier a, , Katia Stankovic Stojanovic b, Jean-François Bergerot c, Christiane Broussolle a, Pascal Sève a
a Department of Internal Medicine, Hôpital de la Croix-Rousse, 93, Grande-Rue de la Croix-Rousse, 69317 Lyon Cedex 04, France 
b Department of Internal Medicine, Hôpital Tenon, Assistance publique–Hôpitaux de Paris (AP–HP), Centre de référence de la fièvre méditerranéenne familiale, Université Paris 6 Pierre- et Marie-Curie (UPMC), Paris, France 
c Department of Radiology, Hôpital de la Croix-Rousse, 93, Grande-Rue de la Croix-Rousse, 69317 Lyon Cedex 04, France 

Corresponding author.
Abstract

Familial Mediterranean fever is an autosomal-recessive autoinflammatory disorder more commonly observed in Mediterranean populations and characterized by recurrent episodes of fever, serositis, myalgia and arthritis. There is rarely any association with spondyloarthritis. The most important long-term complication is progressive systemic type AA amyloidosis. Treatment with colchicine is effective in reducing the frequency of attacks and prevents the development of amyloidosis. However, 5% of cases are considered resistant to colchicine. We here describe the case of a 39-year-old man, with a history of arthritis, arthralgias, and sacroiliitis in the course of a familial Mediterranean fever. He is homozygous for the M694I mutation in the MEFV gene. He subsequently developed myositis of the right quadriceps muscle confirmed by magnetic resonance imaging, electromyography and histology. He had frequent and severe arthralgias, despite colchicine, then etanercept and adalimumab, impairing his quality of life. The patient was successfully treated with the IL-1 receptor antagonist anakinra with a dramatic improvement of muscular and articular symptoms. To our knowledge, our patient is the first patient with coexisting FMF, spondyloarthritis and myositis responding to anakinra treatment. Moreover this is the second case in the literature of myositis associated with familial Mediterranean fever.

The full text of this article is available in PDF format.

Keywords : Familial Mediterranean fever, Spondyloarthritis, Myositis, Myalgia anakinra




© 2013  Société française de rhumatologie@@#104156@@